Reusable diagnostic medical tester
11249074 · 2022-02-15
Inventors
Cpc classification
Y02B90/10
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02A90/10
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
G01N33/5302
PHYSICS
A61B5/14507
HUMAN NECESSITIES
H01M2250/30
ELECTRICITY
H01M8/16
ELECTRICITY
H01M14/00
ELECTRICITY
A61B5/4343
HUMAN NECESSITIES
A61B5/4845
HUMAN NECESSITIES
G16H10/40
PHYSICS
A61B2562/0295
HUMAN NECESSITIES
Y02E60/50
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
International classification
Abstract
A multi-use testing device is disclosed that is able to test a user fluid or dissolved tissue samples for a medical condition comprising, e.g.: blood related, heart (FABS enzymes); liver and kidney function; gene mutations; COVID-19; and pregnancy status. The testing device is positioned in a bio-fluid chamber configured to store at least one electrolyte or charging fluid to create a conductive path for electrons emitted by an anode electrode and a cathode electrode to generate electricity to recharge the micro battery. The generated electricity is transferred to power the testing device. The reusable testing device further comprises a computing device configured to control the communication between a user electronic computing device and the testing device. The reusable testing device is dipped into a sample in a container and outputs the encrypted test result for wireless transmission to electronic computing devices.
Claims
1. A multi-use testing device, comprising: a main body having an upper end and a lower end, wherein the main body encloses a self-rechargeable bio-fueling micro battery having at least one biofuel cell, and a bio-membrane configured to diffuse at least one bio-fluid to generate electron flow for recharging the micro battery and supplying a constant power supply to the testing device; a bio-fluid chamber configured to store at least one electrolyte or charging fluid to create a conductive path for electrons emitted by an anode electrode and a cathode electrode to generate electricity to recharge the micro battery, wherein the generated electricity is transferred to power the testing device, and a computing device configured to control the communication between a user electronic computing device and the testing device, wherein the testing device is dipped into a sample in a container and outputs the test result.
2. The testing device of claim 1, is a reusable pregnancy tester.
3. The testing device of claim 1, wherein the computing device comprises a processor and a memory in communication with the processor configured to store a set of instructions executable by the processor.
4. The testing device of claim 1, wherein the computing device is kept in the electrolyte to recharge the micro battery.
5. The testing device of claim 1, wherein the electrolyte is any one of lemon juice, orange juice, pineapple juice, and sour juice.
6. The testing device of claim 1, wherein the lower end of the testing device is dipped into the sample being tested.
7. The testing device of claim 1, wherein the sample is user's urine.
8. The testing device of claim 1, is wirelessly updated for testing one or more diseases found in the sample.
9. The testing device of claim 3, wherein the computing device processor stores instructions for testing for one or more diseases comprising: heart attack, bacterial or viral infections, coronavirus, cancer, and malaria.
10. The testing device of claim 9, wherein the coronavirus is COVID-19.
11. The testing device of claim 1, wherein the biofuel cells are able to generate and/or store electricity by one or more biofuel cells to recharge the micro battery, and transfers the generated electricity from the micro battery to power the testing device.
12. A method of using a multi-use testing device, comprising the steps of: a) providing a testing device comprising: i) a main body having an upper end and a lower end, wherein the main body encloses a self-rechargeable bio-fueling micro battery having at least one bio-fuel cell and a bio-membrane configured to diffuse at least one bio-fluid to generate electron flow for recharging the micro battery and supplying a constant power supply to the reusable testing device; ii) a bio-fluid chamber configured to store at least one electrolyte or charging fluid to create a conductive path for electrons emitted by an anode electrode and a cathode electrode to generate electricity to recharge the micro battery, wherein the generated electricity is transferred to power the testing device; iii) a computing device configured to control the communication between a user electronic computing device and the testing device, wherein the testing device is dipped into a sample in a container and outputs the test result; b) injecting or diffusing an electrolyte or charging fluid to create a conductive path for electrons emitted by the anode electrode and the cathode electrode to generate electricity to recharge the micro battery and/or to power the testing device; c) generating and/or storing electricity by one or more bio-fuel cells to recharge the micro battery, and transferring the generated electricity from the micro battery to power the testing device, and d) placing the testing device into a sample of a user being tested to analyze and output the test result.
13. The method of claim 12, wherein the sample comprises a user's urine, blood, and/or saliva.
14. The method of claim 12, wherein the sample is any user body fluid or tissue comprising a user's genetic material for use in a genetic test.
15. The method of claim 12, wherein the electrolyte is any one of lemon juice, orange juice, pineapple juice, and sour juice.
16. The method of claim 12, wherein the reusable testing device is wirelessly updated for testing one or more diseases found in the sample.
17. The method of claim 12, wherein the computing device processors stores instructions for testing for one or more diseases comprising: heart attack, bacterial and viral infections, coronavirus, cancer, and malaria.
18. The testing device of claim 17, wherein the coronavirus is COVID-19.
19. The method of claim 12, wherein the computing device analyzes and displays the test results on the testing device, or wirelessly transmits data to a user electronic computing device.
20. The method of claim 19, wherein the test result is encrypted for wireless transmission to the user's electronic computing device and to a doctor's electronic computing device.
Description
BRIEF DESCRIPTION OF DRAWINGS
(1) The foregoing summary, as well as the following detailed description of the invention, is better understood when read in conjunction with the appended drawings. For the purpose of illustrating the invention, exemplary constructions of the invention are shown in the drawings. However, the invention is not limited to the specific methods and structures disclosed herein. The description of a method step or a structure referenced by a numeral in a drawing is applicable to the description of that method step or structure shown by that same numeral in any subsequent drawing herein.
(2)
(3)
(4)
DETAILED DESCRIPTION OF EMBODIMENTS
(5) A description of embodiments of the present invention will now be given with reference to the Figures. It is expected that the present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive.
(6) Referring to
(7) In one embodiment, the reusable testing device 100 is kept in the bio-fluid chamber 102 to charge the micro battery. In one embodiment, the bio-fluid chamber 102 is filled with the electrolyte 104. In one embodiment, the electrolyte 104 is configured to create a conductive path for electrons emitted by an anode electrode and a cathode electrode to generate electricity to recharge the micro battery. In one embodiment, the generated electricity is transferred to power the reusable testing device 100. In some embodiments, the electrolyte 104 could be, but not limited to, lemon juice, orange juice, pineapple juice, and sour juice. In an exemplary embodiment, the electrolyte 104 is lemon juice.
(8) Referring to
(9) In one embodiment, the reusable testing device 100 further comprises a computing device 114. In one embodiment, as illustrated in
(10) The wireless transmissions from the testing device may also be encrypted, such as per the methods disclosed in U.S. Pat. No. 9,723,433 B2 that issued on Aug. 1, 2017 and is entitled “Systems and methods for wireless communication with implantable and body worn devices” (e.g. see
(11) In one embodiment, the computing device 114 is configured to control the communication between a user electronic computing device and the reusable testing device 100. In one embodiment, the reusable testing device 100 is dipped into the sample 118 in a container 116 and outputs the test result. In one embodiment, the user electronic computing 122 device could be, but not limited to, a computer, a laptop, a smartphone, a remote device, a personal digital assistant (PDA), a mobile phone, and a tablet.
(12) User electronic computing 122 device may further comprise a mobile application 124 of the present invention for interpreting and displaying test results, and may further comprise instructions on how to use the test device. The mobile application comprises one or more non-transitory computer-readable storage media having computer-executable instructions stored thereon which, when executed by one or more user electronic computing devices, cause it to perform operations to, e.g. receive and display data.
(13) In one embodiment, the computing device 114 is kept in the electrolyte 104 as shown in
(14) In one embodiment, a method of using the reusable testing device 100 comprises the following steps. At one step, a self-rechargeable bio-fueling micro battery is provided. In one embodiment, the micro battery has a bio-membrane (see
(15) At another step, electricity is generated by one or more bio-fuel cells to recharge the micro battery. In one embodiment, the generated electricity is transferred from the micro battery to the reusable testing device 100, thereby powering the reusable testing device 100 without the need for any additional or external power source. At another step, the reusable testing device 100 is dipped into a sample 118 of a user being tested to output the test result. In an exemplary embodiment, the reusable testing device is configured to test pregnancy by the user in the home by themself. In one embodiment, the reusable testing device 100 is wirelessly updated for testing other diseases found via the sample 118. In one embodiment, the reusable testing device 100 further could be reprogrammed to detect other diseases including, but not limited to, heart attack, coronavirus, cancer, and malaria.
(16) In one embodiment, the reusable testing device 100 is used to detect malaria from a sample collected from the user. The sample could contain malaria Plasmodium falciparum hrpz, which is a poly-histidine antigen. In one embodiment, the poly-hisdine is rich in protein-2. In one embodiment, the reusable testing device 100 could also be used to conduct urine test for coronary disease, where the protein expressions or biomarkers provide about 90% accurate coronary test result. In one embodiment, the reusable testing device 100 could be used to detect thyroid tumor markers level and liver fibrosis. In one embodiment, the reusable testing device 100 could be a prostrate cancer test kit. In some embodiments, the reusable testing device 100 could also be used to conduct cancer test such as breast cancer urine test, PSA (Prostate-Specific Antigen) urine test, prostrate urine risk (PUR) test, and prostrate urine test. In some embodiments, the reusable testing device 100 could be used for urine test such as malaria urine test, cancer urine test, heart attack urine test, and other urine test for other diseases.
(17) Advantageously, the reusable testing device provides easy, reliable, and reusable pregnancy testing procedure. The reusable testing device provides allows women to test the pregnancy in a home by themself. The pregnancy testing procedure is easy and inexpensive. The reusable testing device is rechargeable and reusable. The reusable testing device could be recharged using the self-rechargeable bio-fueling micro battery without the need of additional or external power source. Further, the reusable testing device could be reprogrammed to detect other viruses and diseases such as heart attack, coronavirus, cancer, and malaria.
(18) Micro-Battery Vs Generator
(19) In an embodiment, the reusable testing device is powered by a hand cranked mini generator well known in the art. In another embodiment, a micro-battery within or attached to the reusable testing device is used, such as a standard replaceable or recharged micro-battery well known in the art. In a preferred embodiment, a micro-battery using a bio-fuel as disclosed herein is used.
(20)
(21)
(22) As further illustrated in
(23) In the embodiment shown in
(24) As illustrated in
(25) Once the micro-battery is fully charged, the user removes the stick-main body 116 from the biofluid chamber 102 and inserts it into the container 116 which stores a user's bodily sample (e.g. urine, blood, saliva, etc.) to make contact with the computing device 114 to analyze and display the test results (either on the stick at 130, or via wirelessly transmitting to a user electronic computing device via a wireless network).
(26) Methods of computing test results are well known in the art specific to each test type. For example, in a pregnancy test, the main body 106 further comprises test strips able to detect the presence of pregnancy hormone human chorionic gonadotrophin (hCG). And in blood glucose tests, the main body components for generating electrical current through a blood sample to read the level of resistance. And for cancer and infectious diseases, the main body further comprises components for detecting antibodies specific to the disease.
(27) Preferred embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. It should be understood that the illustrated embodiments are exemplary only and should not be taken as limiting the scope of the invention.
(28) The foregoing description comprise illustrative embodiments of the present invention. Having thus described exemplary embodiments of the present invention, it should be noted by those skilled in the art that the within disclosures are exemplary only, and that various other alternatives, adaptations, and modifications may be made within the scope of the present invention. Merely listing or numbering the steps of a method in a certain order does not constitute any limitation on the order of the steps of that method. Many modifications and other embodiments of the invention will come to mind to one skilled in the art to which this invention pertains having the benefit of the teachings in the foregoing descriptions. Although specific terms may be employed herein, they are used only in generic and descriptive sense and not for purposes of limitation. Accordingly, the present invention is not limited to the specific embodiments illustrated herein.